FDA approves hydroxychloroquine as emergency coronavirus treatment
The 'known and potential' benefits outweigh the 'known and potential risks', says the regulator
The US drugs regulator has controversially approved the anti-malarial drugs hydroxychloroquine and chloroquine to treat seriously ill patients with COVID-19.
The emergency approval for use of the older-generation drugs in hospitals was granted by the FDA over the weekend, despite concern over a lack of safety or efficacy data for this indication.
